Status:
UNKNOWN
Chlorhexidine and Garlic Extract as Potential Topical Virucidal Therapeutic Agents of Non-Genital Warts
Lead Sponsor:
Assiut University
Conditions:
Non-Genital Warts
Eligibility:
All Genders
Phase:
NA
Brief Summary
Aim(s) of the Research: 1. Evaluate the efficacy and safety of topical chlorhexidine (2%) solution vs garlic extract (15%) solution in treating non-genital warts. 2. Explore possible relation between...
Detailed Description
Cutaneous warts or verruca are common, benign skin growths caused by human papilloma virus (HPV). There are several therapeutic modalities for warts: include destructive agents (keratolytics, cryothe...
Eligibility Criteria
Inclusion
- Patients with the clinical diagnosis of common or plantar warts.
Exclusion
- Pregnancy and lactation.
- Chronic systemic diseases such as chronic renal failure, hepatic insufficiency, and cardiovascular disorders.
- Patients with inflamed lesions
- Use of systemic or topical treatments during the last month before enrollment.
- Individuals with history of allergic reactions to garlic or chlorhexidine
- Patient with generalized dermatitis or allergic skin disorders
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06077032
Start Date
November 1 2023
End Date
December 1 2025
Last Update
October 16 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.